3.23
Pyxis Oncology Inc Aktie (PYXS) Neueste Nachrichten
What makes Pyxis Oncology Inc. stock attractive to growth fundsQuarterly Profit Report & Fast Entry and Exit Trade Plans - newser.com
Pyxis Oncology (PYXS) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Yahoo Finance
Why Pyxis Oncology Inc. stock is a value investor pickWeekly Stock Analysis & Risk Managed Investment Strategies - newser.com
Will Pyxis Oncology Inc. stock continue upward momentumMarket Growth Report & Community Consensus Picks - newser.com
Strategies to average down on Pyxis Oncology Inc.2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Pyxis Oncology to Present Translational Data and Key - GlobeNewswire
ctDNA reduction in 37 clinical samples: Pyxis Oncology presents MICVO translational findings at ESMO & AACR 2025 - Stock Titan
Smart tools for monitoring Pyxis Oncology Inc.’s price action2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Can Pyxis Oncology Inc. stock beat analyst upgradesTrade Analysis Report & Free Low Drawdown Momentum Trade Ideas - newser.com
How risky is Pyxis Oncology Inc. stock nowJuly 2025 News Drivers & High Conviction Buy Zone Picks - newser.com
Will Pyxis Oncology Inc. stock deliver better than expected guidance2025 Price Targets & Entry Point Confirmation Alerts - newser.com
Full technical analysis of Pyxis Oncology Inc. stockJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Developing predictive dashboards with Pyxis Oncology Inc. data2025 Analyst Calls & Technical Confirmation Trade Alerts - newser.com
Pyxis Oncology Gains 70%, Insider Trades Reap Benefit - 富途牛牛
Pyxis Oncology (NASDAQ:PYXS) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
Will Pyxis Oncology Inc. see short term momentumVolume Spike & Pattern Based Trade Signal System - newser.com
Is Pyxis Oncology Inc. stock undervalued vs historical averages2025 Trading Volume Trends & Community Verified Swing Trade Signals - newser.com
Is Pyxis Oncology Inc. stock a top pick in earnings seasonRate Cut & AI Enhanced Trading Signals - newser.com
Real time pattern detection on Pyxis Oncology Inc. stockMarket Growth Report & Community Consensus Picks - newser.com
Pyxis Oncology, Inc. Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets, Effective October 9, 2025 - MarketScreener
Pyxis Oncology appoints Alex Kane as SVP of investor relations By Investing.com - Investing.com Australia
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets - Quiver Quantitative
Pyxis Oncology appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets - MarketScreener
Volume spikes in Pyxis Oncology Inc. stock – what they mean2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - newser.com
What data driven models say about Pyxis Oncology Inc.’s future2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
How institutional ownership impacts Pyxis Oncology Inc. stockMarket Sentiment Review & Daily Momentum Trading Reports - newser.com
What to do if you’re stuck in Pyxis Oncology Inc.Trade Risk Summary & Free High Return Stock Watch Alerts - newser.com
Sector ETF performance correlation with Pyxis Oncology Inc.2025 Investor Takeaways & Low Volatility Stock Recommendations - newser.com
Detecting support and resistance levels for Pyxis Oncology Inc.July 2025 Highlights & Reliable Entry Point Trade Alerts - newser.com
Wall Street Zen Downgrades Pyxis Oncology (NASDAQ:PYXS) to Sell - Defense World
Pyxis Oncology (NASDAQ:PYXS) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Quantitative breakdown of Pyxis Oncology Inc. recent move2025 Technical Patterns & Stepwise Entry/Exit Trade Alerts - newser.com
Live market analysis of Pyxis Oncology Inc.July 2025 Intraday Action & Growth Oriented Trade Recommendations - newser.com
Can swing trading help recover from Pyxis Oncology Inc. lossesAnalyst Downgrade & Pattern Based Trade Signal System - newser.com
Pyxis Oncology, Inc.'s (NASDAQ:PYXS) top owners are retail investors with 39% stake, while 21% is held by institutions - Yahoo Finance
What analysts say about Pyxis Oncology Inc stockHigh Frequency Trading Trends & Next-Level Stock Intelligence, Now Free - earlytimes.in
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):